LEADER 04508nam 2201105 450 001 9910810300903321 005 20231110232823.0 010 $a0-2280-1350-X 010 $a0-2280-1349-6 024 7 $a10.1515/9780228013495 035 $a(CKB)5720000000119837 035 $a(MiAaPQ)EBC30159064 035 $a(Au-PeEL)EBL30159064 035 $a(DE-B1597)657780 035 $a(DE-B1597)9780228013495 035 $a(BIP)082050092 035 $a(EXLCZ)995720000000119837 100 $a20230913d2022 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRemedicalizing cannabis $escience, industry, and drug policy /$fSuzanne Taylor 205 $a1st ed. 210 1$aLondon, England :$cMcGill-Queen's University Press,$d[2022] 210 4$dİ2022 215 $a1 online resource (305 pages) 225 1 $aIntoxicating Histories 311 $a0-2280-1140-X 320 $aIncludes bibliographical references and index. 327 $tFront Matter -- $tContents -- $tFigures -- $tAcknowledgements -- $tAbbreviations -- $tIntroduction -- $tUnderstanding Cannabis: Pharmacology, Laboratory Research, and Drug Control, 1964?82 -- $tCannabis in the Clinic: Clinical Pharmacology and the Therapeutic Applications of Cannabis, 1973?82 -- $tEvidence-Based Policy? The Development of Expert Committees, 1972?82 -- $tIndustrializing Cannabis: The Pharmaceutical Industry and the Remedicalization of Cannabis, 1973?2001 -- $tForces of Necessity: Lay Advocacy and the Remedicalization of Cannabis, 1973?2001 -- $tEstablishing Therapeutic Cannabis: The Role of Expert Advice, 1997?2001 -- $tFrom Anecdotal to Evidence-Based Medicine: The Role of Clinical Trials, 1995?2005 -- $tAccessing Cannabis-Based Medicinal Products, 2009?21 -- $tConclusion -- $tNotes -- $tBibliography -- $tIndex 330 $aRemedicalizing Cannabis discovers the historical ins and outs of cannabis as a botanical product with medical applications. Addressing questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it reveals how we have arrived at the current classification of cannabis as a medical product. 410 0$aIntoxicating Histories 606 $aCannabis$xGovernment policy$zGreat Britain$xHistory$y20th century 606 $aCannabis$xGovernment policy$zGreat Britain$xHistory$y21st century 606 $aCannabis$xTherapeutic use$zGreat Britain$xHistory$y20th century 606 $aCannabis$xTherapeutic use$zGreat Britain$xHistory$y21st century 606 $aMarijuana industry$zGreat Britain$xHistory$y20th century 606 $aMarijuana industry$zGreat Britain$xHistory$y21st century 610 $aACMD. 610 $aCBD. 610 $aCBMPs. 610 $aCannabinoids. 610 $aGriffith Edwards. 610 $aINCB. 610 $aMS. 610 $aSativex. 610 $aScience. 610 $aSir William Paton. 610 $aTHC. 610 $aWorld Health Organization. 610 $abio tech industry. 610 $aboundary substance. 610 $acannabis oil. 610 $aclinical trials. 610 $acommittees. 610 $adrug policy. 610 $adrugs. 610 $aepilepsy. 610 $aexchange. 610 $aexpert advice. 610 $aillicit substances. 610 $aindustry. 610 $ainternational agencies. 610 $aknowledge. 610 $amarijuana. 610 $amisuse. 610 $aoral history. 610 $apatient access. 610 $apharmaceutical. 610 $apharmacology. 610 $aphytopharmacy. 610 $aplant based medicine. 610 $apolicy. 610 $apot. 610 $apsychopharmacology. 610 $atinctures. 610 $auncertainty. 610 $auser activism. 615 0$aCannabis$xGovernment policy$xHistory 615 0$aCannabis$xGovernment policy$xHistory 615 0$aCannabis$xTherapeutic use$xHistory 615 0$aCannabis$xTherapeutic use$xHistory 615 0$aMarijuana industry$xHistory 615 0$aMarijuana industry$xHistory 676 $a362.295561 700 $aTaylor$b Suzanne$f1909-2004,$01635557 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910810300903321 996 $aRemedicalizing cannabis$93976412 997 $aUNINA